Literature DB >> 8627750

A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis.

M Nassal1, A Rieger.   

Abstract

Human hepatitis B virus (HBV) is a small DNA virus that replicates inside the viral nucleocapsid by reverse transcription of an RNA intermediate. Encapsidation of this RNA pregenome is mediated by the interaction of the viral replication enzyme P with the structured 5'-proximal RNA element epsilon; replication was thought to start in the 3'-proximal direct repeat DR1*. However, recent data obtained with the duck hepatitis B virus indicated a novel, discontinuous mechanism of negative-strand DNA synthesis. Here we demonstrate, using DNA transfection of complete HBV genomes, that the 3'-half of a 6-nucleotide bulge in HBV epsilon whose primary sequence is not important for encapsidation serves as template for a short DNA primer that is subsequently transferred to DR1*. Apparently, P protein copies any template sequence that does not interfere with epsilon structure; however, altered primary sequences can induce polymerase stuttering, resulting in extended primers containing more than one equivalent of the template sequence. The importance of the bulged structure is emphasized by the dependence of primer length on bulge size. Transfer specificity is in part controlled by sequence complementarity. The strategy of using the 5' encapsidation signal as the origin of replication for discontinuous negative-strand DNA synthesis, common to mammalian and avian hepadnaviruses, suggests the evolutionary origin of hepatitis B viruses to lie between that of modern retroviruses and primitive retroelements like the Mauriceville retroplasmid.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627750      PMCID: PMC190133     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Two regions of an avian hepadnavirus RNA pregenome are required in cis for encapsidation.

Authors:  J Calvert; J Summers
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

2.  Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase.

Authors:  F Zoulim; C Seeger
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

3.  The Mauriceville plasmid reverse transcriptase can initiate cDNA synthesis de novo and may be related to reverse transcriptase and DNA polymerase progenitor.

Authors:  H Wang; A M Lambowitz
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

4.  Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer.

Authors:  J E Tavis; S Perri; D Ganem
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  The stem-loop structure of the cis-encapsidation signal is highly conserved in naturally occurring hepatitis B virus variants.

Authors:  T Laskus; J Rakela; D H Persing
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

6.  Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal.

Authors:  A S Lok; U Akarca; S Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 7.  Host control of yeast dsRNA virus propagation and expression.

Authors:  R B Wickner
Journal:  Trends Microbiol       Date:  1993-11       Impact factor: 17.079

8.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

9.  Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription.

Authors:  M Weber; V Bronsema; H Bartos; A Bosserhoff; R Bartenschlager; H Schaller
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy.

Authors:  R A Crowther; N A Kiselev; B Böttcher; J A Berriman; G P Borisova; V Ose; P Pumpens
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

View more
  74 in total

1.  Mutations that increase in situ priming also decrease circularization for duck hepatitis B virus.

Authors:  D D Loeb; R Tian
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins.

Authors:  Jianming Hu; David Toft; Dana Anselmo; Xingtai Wang
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Distinct requirement for two stages of protein-primed initiation of reverse transcription in hepadnaviruses.

Authors:  Xingtai Wang; Jianming Hu
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  The majority of duck hepatitis B virus reverse transcriptase in cells is nonencapsidated and is bound to a cytoplasmic structure.

Authors:  E Yao; Y Gong; N Chen; J E Tavis
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase.

Authors:  Xingtai Wang; Xiaofeng Qian; Hwai-Chen Guo; Jianming Hu
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90.

Authors:  J Hu; D Anselmo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  cis-Acting sequences that contribute to the synthesis of relaxed-circular DNA of human hepatitis B virus.

Authors:  Ning Liu; Lin Ji; Megan L Maguire; Daniel D Loeb
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

8.  A novel cis-acting element facilitates minus-strand DNA synthesis during reverse transcription of the hepatitis B virus genome.

Authors:  Myeong-Kyun Shin; Jehan Lee; Wang-Shick Ryu
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Establishment and primary application of a mouse model with hepatitis B virus replication.

Authors:  Feng-Jun Liu; Li Liu; Fang He; Su Wang; Tao-You Zhou; Cong Liu; Lin-Yu Deng; Hong Tang
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

10.  Protein-primed terminal transferase activity of hepatitis B virus polymerase.

Authors:  Scott A Jones; Jianming Hu
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.